Real-World Study on the Burden of Hidradenitis Suppurativa
ConditionHidradenitis Suppurativa (HS)
Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorPeriPharm
About this trial
Despite the significant impact of HS on patients' quality of life (QoL) and daily functioning, there remains limited real-world evidence describing the burden of this condition in Canada. HS is an under-recognized and often misdiagnosed condition, with a substantial psychological and physical burden on patients. Understanding the real-world experiences of individuals living with HS in Canada can help identify unmet needs and inform patient-centered care approaches.
Eligibility criteria
Qualifiers
Patient diagnosed with HS;
Aged ≥18 years;
Able to read and understand French or English;
Willing and able to provide written informed consent.
Disqualifiers
None
Trial design
Treatments tested in this trial
- No Intervention: Observational Cohort
Treatment groups
100 Participants
are divided into 1 treatment groupLocations
Sponsors and collaborators
Source ClinicalTrials.gov